SecBot SecBot
SECBOTREPLAY Home › Report › VIR

VIR · Multiple top executives at Vir Biotechnology, including the CEO, CFO,…

Vir Biotechnology, Inc. · CLUSTER filed Feb 22, 2026 at 19:00 ET

At the news

NEUTRALIMPACT 4/10

CLUSTER filed Feb 22, 2026 at 19:00 ET

Multiple top executives at Vir Biotechnology, including the CEO, CFO, and Chief Medical Officer, sold shares in a coordinated cluster over two days, totaling over $206,000 in sales. The same insiders also received stock awards totaling 450,000 shares, indicating a routine grant or vesting event. The sales appear to be part of a planned transaction, likely related to tax or diversification strategies following the award vesting.

  • CEO Marianne De Backer sold $141,894 worth of shares, the largest individual sale.
  • All four C-suite insiders sold shares at $7.4528 per share on 2026-02-23, immediately after receiving large stock awards on 2026-02-22.
  • Total sales value: $205,159.35 across 27,662 shares.
  • Insiders collectively received 450,000 shares via awards at $0 cost, consistent with vesting of prior grants.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access